Target Name: LOC107985511
NCBI ID: G107985511
Review Report on LOC107985511 Target / Biomarker Content of Review Report on LOC107985511 Target / Biomarker
LOC107985511
Other Name(s): LOC107985511 variant X2 | Uncharacterized LOC107985511, transcript variant X2 | uncharacterized LOC107985511

CD11b: A Potential Drug Target Or Biomarker

LOC107985511 is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 18 and encodes a protein known as CD11b.

CD11b is a transmembrane protein that is expressed in many tissues throughout the body, including the blood, skin, and nervous system. It is involved in several different cellular processes, including adhesion, migration, and signaling.

Studies have suggested that CD11b may be a potential drug target or biomarker for the treatment of various diseases, including cancer. For example, some researchers have found that high levels of CD11b expression are associated with poor prognosis in patients with pancreatic cancer, a type of cancer that is often treated with chemotherapy.

Additionally, other studies have suggested that CD11b may be a potential biomarker for pancreatic cancer, as it has been found to be downregulated in pancreatic cancer samples compared to healthy tissue. This suggests that measuring levels of CD11b in the body may be a useful diagnostic tool for pancreatic cancer.

Another potential application of CD11b as a drug target is its role in immune surveillance. CD11b is known to be expressed in immune cells, including dendritic cells, and has been shown to play a role in regulating the immune response.

Research has suggested that CD11b may be a potential target for cancer immunotherapy, as it has been found to be expressed in the immune cells that are responsible for recognizing and attacking foreign tumors. By targeting CD11b with drugs or other therapeutic agents, researchers may be able to enhance the body's immune response against cancer cells.

Another potential application of CD11b as a drug target is its role in the development of neurodegenerative diseases, such as Alzheimer's disease. Research has suggested that CD11b may be involved in the production of amyloid, a protein that is hallmark of Alzheimer's disease, and that may contribute to the development of neurodegeneration.

In addition to its potential as a drug target or biomarker, CD11b has also been studied for its potential role in the development and progression of various diseases. For example, some researchers have found that CD11b is downregulated in the brains of people with Alzheimer's disease, which suggests that it may be an important factor in the development and progression of this disease.

Overall, CD11b is a gene that has significant potential as a drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand its role in these processes and to develop safe and effective therapies that target CD11b.

Protein Name: Uncharacterized LOC107985511

The "LOC107985511 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107985511 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC107985544 | LOC107985590 | LOC107985593 | LOC107985688 | LOC107985690 | LOC107985811 | LOC107985830 | LOC107985854 | LOC107985855 | LOC107985869 | LOC107985870 | LOC107985892 | LOC107985935 | LOC107985940 | LOC107985954 | LOC107985960 | LOC107985969 | LOC107985979 | LOC107985981 | LOC107985984 | LOC107985986 | LOC107985996 | LOC107986003 | LOC107986009 | LOC107986018 | LOC107986022 | LOC107986023 | LOC107986051 | LOC107986056 | LOC107986092 | LOC107986115 | LOC107986139 | LOC107986141 | LOC107986142 | LOC107986146 | LOC107986148 | LOC107986166 | LOC107986178 | LOC107986186 | LOC107986195 | LOC107986203 | LOC107986205 | LOC107986215 | LOC107986223 | LOC107986229 | LOC107986257 | LOC107986272 | LOC107986286 | LOC107986291 | LOC107986297 | LOC107986298 | LOC107986300 | LOC107986362 | LOC107986368 | LOC107986385 | LOC107986400 | LOC107986420 | LOC107986429 | LOC107986440 | LOC107986451 | LOC107986452 | LOC107986453 | LOC107986454 | LOC107986469 | LOC107986517 | LOC107986522 | LOC107986528 | LOC107986537 | LOC107986544 | LOC107986545 | LOC107986561 | LOC107986589 | LOC107986594 | LOC107986595 | LOC107986597 | LOC107986598 | LOC107986606 | LOC107986613 | LOC107986622 | LOC107986623 | LOC107986626 | LOC107986636 | LOC107986649 | LOC107986666 | LOC107986764 | LOC107986766 | LOC107986770 | LOC107986771 | LOC107986772 | LOC107986774 | LOC107986776 | LOC107986777 | LOC107986781 | LOC107986787 | LOC107986800 | LOC107986816 | LOC107986820 | LOC107986836 | LOC107986844 | LOC107986873